& Reed, D
"These findings may inform shared decision making when considering GLP- 1 receptor agonist therapy and highlight the need for further evaluation of dermatological outcomes in future studies." The study involved a large number of people: 12,004 patients using GLP-1 drugs were compared to 15,221 using SGLT-2 inhibitors, with an additional 11,964 GLP-1 users compared to 11,233 using DPP-4 inhibitors
At AgeWell Medicine & Aesthetics, our patients frequently experience: Improved sleep quality Enhanced muscle tone and increased lean muscle mass Reduction in body fat Faster recovery from injuries Increased energy and vitality Support for healthy aging and longevity At AgeWell Medicine & Aesthetics, your health and safety are our top priorities
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2(4), 259269
Prevention of unnecessary illness
You dont have to go through it alone